Regeneron Pharmaceuticals | REGN - مصروفات التشغيل





مصروفات التشغيل تغيير تاريخ
AbbVie USD 10.27B 1000K 2026-06
Agenus USD -199.08M 22.15M 2026-06
Agios Pharmaceuticals USD 130.77M 10.77M 2026-03
Alnylam Pharmaceuticals USD 1.11B 52.78M 2026-09
Amgen USD 11.69B 6.9B 2026-06
Astellas Pharma JPY 455.56B 33.8B 2026-06
AstraZeneca USD 12.22B 4.04B 2026-06
Biogen USD 2.32B 663.6M 2026-09
BioMarin Pharmaceutical USD 6.32B 5.69B 2026-06
Bristol-Myers Squibb USD 23.4B 1.08B 2026-09
Eli Lilly USD 10.52B 496M 2026-06
Gilead Sciences USD 13.04B 9.09B 2026-09
GlaxoSmithKline GBP 6.03B 227M 2026-09
Incyte USD 5.64B 4.67B 2026-09
Ionis Pharmaceuticals USD 370.24M 6.24M 2026-06
J&J USD 18.93B 1.09B 2026-09
Kyowa Hakko Kirin JPY 122.9B 13.95B 2026-06
Merck USD 10.75B 5.02B 2026-09
Moderna USD 960M 817M 2026-06
Neurocrine Biosciences USD 739.1M 139.2M 2026-06
Novartis USD 10.2B 912M 2026-06
Novartis USD 9.29B 507M 2026-03
Pfizer USD 85.19B 4.91B 2026-06
Puma Biotechnology USD 49.26M 3.2M 2024-06
Regeneron Pharmaceuticals USD 33.5B 1.79B 2026-09
Roche Holding CHF 18.9B 2.12B 2026-06
Sanofi EUR 8.98B 1.73B 2026-03
Sarepta Therapeutics USD 387.96M 15.59M 2026-06
Teva Pharmaceutical Industries USD 3.92B 691M 2026-06
Ultragenyx Pharmaceutical USD 289M 16M 2026-06
United Therapeutics USD 6.4B 499.2M 2026-06
Vertex Pharmaceuticals USD 2.07B 217.1M 2026-06